Contact this trialFirst, we need to learn more about you.
Androgen Synthesis Inhibitor
Apalutamide + Abiraterone Acetate + Prednisone for Prostate Cancer
Recruiting1 awardPhase 3
New Haven, Connecticut
This trial will compare the effectiveness of two treatments for metastatic castration-resistant prostate cancer: apalutamide with abiraterone acetate and prednisone, versus abiraterone acetate and prednisone alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.